Ustekinumab may have therapeutic effects on autoimmune thyroid disease
Abstract Interleukin (IL)-12 and IL-23 play crucial roles in initiating and maintaining autoimmunity, which is implicated in autoimmune thyroid disease (AITD). This study evaluated the effect of ustekinumab, a biologic agent targeting IL-12/23, on AITD in patients with inflammatory bowel disease (IB...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Nature Portfolio
2025-12-01
|
| Ráidu: | Scientific Reports |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1038/s41598-025-31266-w |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|